Literature DB >> 1508204

The DNA-binding defect observed in major histocompatibility complex class II regulatory mutants concerns only one member of a family of complexes binding to the X boxes of class II promoters.

C Herrero Sanchez1, W Reith, P Silacci, B Mach.   

Abstract

The X box of major histocompatibility complex class II promoters is essential for proper expression of class II genes. Here we show that two distinct protein-DNA complexes (A and B), which exhibit similar binding characteristics and identical contact points on the X box, can be formed. This suggests the existence of a family of related X box-binding factors. Complex B (and not complex A) is specifically affected in primary combined immunodeficiency, a congenital defect in class II gene regulation. RFX1, the first X box-binding protein cloned, encodes a functionally relevant factor present in complex A and not in complex B as originally suspected. This report also illustrates the need for caution in correlating specific cloned proteins with nuclear factors identified by DNA-binding assays, particularly when dealing with families of related proteins.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1508204      PMCID: PMC360302          DOI: 10.1128/mcb.12.9.4076-4083.1992

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  30 in total

1.  NF-X, a transcription factor implicated in MHC class II gene regulation.

Authors:  V Kouskoff; R M Mantovani; S M Candéias; A Dorn; A Staub; B Lisowska-Grospierre; C Griscelli; C O Benoist; D J Mathis
Journal:  J Immunol       Date:  1991-05-01       Impact factor: 5.422

Review 2.  Regulation of major histocompatibility complex class-II genes: X, Y and other letters of the alphabet.

Authors:  C Benoist; D Mathis
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

Review 3.  How do different transcription factors binding the same DNA sequence sort out their jobs?

Authors:  W Schaffner
Journal:  Trends Genet       Date:  1989-02       Impact factor: 11.639

4.  In vivo footprinting of MHC class II genes: bare promoters in the bare lymphocyte syndrome.

Authors:  C J Kara; L H Glimcher
Journal:  Science       Date:  1991-05-03       Impact factor: 47.728

5.  Two DNA-binding proteins discriminate between the promoters of different members of the major histocompatibility complex class II multigene family.

Authors:  M Kobr; W Reith; C Herrero-Sanchez; B Mach
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

6.  Leucine zippers of fos, jun and GCN4 dictate dimerization specificity and thereby control DNA binding.

Authors:  T Kouzarides; E Ziff
Journal:  Nature       Date:  1989-08-17       Impact factor: 49.962

7.  Cloning of the major histocompatibility complex class II promoter binding protein affected in a hereditary defect in class II gene regulation.

Authors:  W Reith; E Barras; S Satola; M Kobr; D Reinhart; C H Sanchez; B Mach
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

8.  Magnitude of response of histocompatibility-restricted T-cell clones is a function of the product of the concentrations of antigen and Ia molecules.

Authors:  L A Matis; L H Glimcher; W E Paul; R H Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

9.  Scanning independent ribosomal initiation of the Sendai virus X protein.

Authors:  J Curran; D Kolakofsky
Journal:  EMBO J       Date:  1988-09       Impact factor: 11.598

10.  Co-evolution from yeast to mouse: cDNA cloning of the two NF-Y (CP-1/CBF) subunits.

Authors:  R Hooft van Huijsduijnen; X Y Li; D Black; H Matthes; C Benoist; D Mathis
Journal:  EMBO J       Date:  1990-10       Impact factor: 11.598

View more
  17 in total

1.  Associations and interactions between bare lymphocyte syndrome factors.

Authors:  A M DeSandro; U M Nagarajan; J M Boss
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

2.  Definition of a novel complementation group in MHC class II deficiency.

Authors:  A Peijnenburg; B Godthelp; A van Boxel-Dezaire; P J van den Elsen
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

3.  The major histocompatibility complex class II promoter-binding protein RFX (NF-X) is a methylated DNA-binding protein.

Authors:  X Y Zhang; N Jabrane-Ferrat; C K Asiedu; S Samac; B M Peterlin; M Ehrlich
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

4.  Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y.

Authors:  W Reith; C A Siegrist; B Durand; E Barras; B Mach
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

5.  Characterization of the expressed CIITA allele in the class II MHC transcriptional mutant RJ2.2.5.

Authors:  J A Brown; X F He; S D Westerheide; J M Boss
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

6.  Locus- and allele-specific DNA-protein interactions in the HLA-DQB1 X box.

Authors:  T L Sukiennicki; L M Shewey; G T Nepom
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

7.  The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element.

Authors:  J A Brown; E M Rogers; J M Boss
Journal:  Nucleic Acids Res       Date:  1998-09-15       Impact factor: 16.971

8.  Mutant human cells defective in induction of major histocompatibility complex class II genes by interferon gamma.

Authors:  C Mao; D Davies; I M Kerr; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

9.  Functional complementation of major histocompatibility complex class II regulatory mutants by the purified X-box-binding protein RFX.

Authors:  B Durand; M Kobr; W Reith; B Mach
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

10.  RFX1 is identical to enhancer factor C and functions as a transactivator of the hepatitis B virus enhancer.

Authors:  C A Siegrist; B Durand; P Emery; E David; P Hearing; B Mach; W Reith
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.